Literature DB >> 20874830

Blood-brain-barrier disruption in chronic canine hypothyroidism.

Theresa Pancotto1, John H Rossmeisl, David L Panciera, Kurt L Zimmerman.   

Abstract

BACKGROUND: Central nervous system (CNS) manifestations of hypothyroidism have been associated with cerebrovascular complications. Reports of cerebrospinal fluid (CSF) abnormalities are rare in hypothyroid dogs.
OBJECTIVE: The aim of this study was to determine if chronic hypothyroidism causes blood-brain-barrier (BBB) abnormalities that are detectable using indirect CSF biomarkers.
METHODS: The study included 18 normal, euthyroid, female mixed-breed dogs. Hypothyroidism was induced by (131) iodine administration in 9 dogs; 9 served as untreated controls. Evaluations included physical and neurologic examination, complete CSF analysis, serum and CSF protein electrophoresis, measurement of plasma vascular endothelial growth factor (VEGF) and serum S-100B concentrations, and calculation of CSF albumin quota (AQ) and were conducted at baseline and 6, 12, and 18 months after induction of hypothyroidism. Data were analyzed using repeated measures ANOVA.
RESULTS: At baseline, differences between groups were not detected for any variable. Throughout the study, controls dogs remained free of neurologic disease and had test variables that remained within reference intervals. Two hypothyroid dogs developed CNS signs during the study, and evidence of cerebrovascular disease was found at necropsy. At 12 and 18 months, the CSF total protein, VEGF, S-100B, and fractional albumin concentrations, and AQ were significantly higher (P<.04) in hypothyroid dogs than controls. Among test variables assayed in serum or plasma, the only significant difference was a higher S-100B concentration in hypothyroid dogs (P=.003) at 18 months.
CONCLUSIONS: BBB integrity is disrupted in chronic hypothyroidism. Significant increases in CSF concentrations of VEGF and S100-B in hypothyroid dogs indicate dysfunction in both endothelial and glial elements of the BBB. ©2010 American Society for Veterinary Clinical Pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874830     DOI: 10.1111/j.1939-165X.2010.00253.x

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  4 in total

1.  International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy.

Authors:  Heidrun Potschka; Andrea Fischer; Wolfgang Löscher; Ned Patterson; Sofie Bhatti; Mette Berendt; Luisa De Risio; Robyn Farquhar; Sam Long; Paul Mandigers; Kaspar Matiasek; Karen Muñana; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Clare Rusbridge; Veronika Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

2.  A case of stiff dog syndrome associated with anti-glutamic acid decarboxylase antibodies.

Authors:  Theresa E Pancotto; John H Rossmeisl
Journal:  J Clin Mov Disord       Date:  2017-05-10

3.  Cerebral Ischemia/Reperfusion Injury in the Hyperthyroid Rat.

Authors:  Somaye Keshavarz; Gholam Abbas Dehghani
Journal:  Iran J Med Sci       Date:  2017-01

4.  Immunosignature Differentiation of Non-Infectious Meningoencephalomyelitis and Intracranial Neoplasia in Dogs.

Authors:  Bathilda B Lake; John Henry Rossmeisl; Julie Cecere; Phillip Stafford; Kurt L Zimmerman
Journal:  Front Vet Sci       Date:  2018-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.